迅速微生物検査市場の2030年までの予測：製品別、方法別、用途別、地域別の世界分析

Stratistics MRCによると、世界の迅速微生物検査市場は2023年に47億米ドルを占め、予測期間中にCAGR 10.8％で成長し、2030年には97億米ドルに達する見込みです。

微生物検査は、微生物による潜在的な健康脅威を早期に特定し、重要な管理ポイントをリアルタイムで監視し、生産プロセスを最適化し、製品の安全性を高め、品質手順全体のコストを下げるために迅速に行われます。迅速微生物検査は、医薬品開発、研究、その他の診断で使用される技術です。迅速微生物検査は、結核やマラリアなどの感染症を迅速に診断するために使用されます。これは下気道感染症の治療に役立ちます。培養に基づく従来の検査と比較すると、これらの検査はより迅速な所見が得られます。

PHACによると、カナダでは2021年に、性感染症、食中毒、呼吸器感染症など、届出可能な感染症の症例が22万5,000件以上報告されました。

感染症の増加

マラリア、HIV、肺炎、結核を含む感染症は、より一般的になりつつあります。HIV、がん、結核、肺炎を含む感染症に対する認識を高めるためのプログラムは、早期発見と予防医療を推進し、より良い治療成績につなげるために普及しています。これらの疾患による世界の負担の増大は、おそらく予測期間を通じて迅速な微生物学的処置に対する需要の大幅な上昇をもたらすであろう。

不十分な医療サービス

低開発国の多くの人々は、医療施設や健康維持に必要な情報へのアクセスが不足しています。さらに、公衆衛生上の大きな障壁は資金不足であり、これが深刻な公衆衛生上の懸念である感染症の問題を悪化させています。さらに、大多数の貧困国の医療システムは、有能な専門家の確保に苦慮しており、迅速な微生物検査のような質の高い医療サービスへのアクセスを提供することが難しいです。これが市場拡大の障害となっています。

食品の安全性に関する懸念の高まり

食品は植物と動物の両方で構成され、一般的にさまざまな微生物を含んでいます。生産段階や消費段階において、食品は自然由来の微生物と接触し、汚染される可能性があります。飲食品部門が最高レベルの製品の安全性と品質を顧客に提供することを保証するため、規制機関は定期的に食品安全法を更新しています。その結果、予測期間を通じて市場の成長が見込まれています。

高い設備コスト

迅速な手順では、旧来のアプローチと比較して機器の初期設定費用が大きくなる可能性があります。資金繰りが厳しい小規模ラボや研究機関にとっては、これが障害となる可能性があります。迅速技術に使用される他の消耗品の中でも、検査キットやカートリッジは高額になる可能性があります。これらの費用は時間とともに蓄積され、最終的には従来の技術に関する費用を上回る可能性があります。これらが市場の拡大を妨げています。

COVID-19影響：

パンデミックの初期段階では、患者の病気を検出するための特定の診断検査は利用できなかった。当初は代替診断検査が使用されたが、あまり有効ではありません。特定のCOVID-19診断検査が利用できなかったため、診断薬メーカーにとっては、診断キットを導入する有利な機会となった。多くの大手企業や各国の新興企業がこの機会を利用し、国内のみならず世界市場に診断キットを投入しました。このような企業は、診断検査需要から得られる機会を活用することで、他の診断薬メーカーよりも優位に立つことができ、ひいてはこのような危機的状況下でも収益を維持するのに役立っています。

予測期間中、細胞成分ベースのセグメントが最大になる見込み

感染症の効果的な治療とコントロールに不可欠な微生物病原体の検出がより正確で高感度であることから、細胞成分ベースのセグメントは予測期間中最大になると予想されます。細胞成分に基づく迅速微生物検査は、食品由来感染症、医療に関連した感染症、感染症など、多くの深刻な症状の診断に使用されています。これらの疾患に対する迅速かつ正確な診断検査の必要性が高まっていることから、市場は今後も拡大し続けると予想されます。

予測期間中、臨床診断検査分野が最も高いCAGRが見込まれる

臨床診断検査分野は、予測期間中に最も高いCAGRが見込まれます。血液、尿、喀痰などの臨床検体中の感染性細菌を同定・分類するために、臨床診断では迅速微生物検査法が採用されています。感染症が一般的になるにつれて、迅速微生物検査法は臨床現場でますます必要とされるようになっています。検査手法の技術的進歩により、検査の精度と効率が向上しているため、業界全体で臨床診断での利用が促進されています。

最大のシェアを占める地域

予測期間中、北米が最大の市場シェアを占めると予測されます。同市場は、医薬品やワクチンの開発に重点が置かれるようになったこと、バイオテクノロジーや製薬研究における最近の研究開発、幅広い微生物検査製品を提供するベンダーが国内に複数存在することなど、多くの要因によって拡大しています。このように、この地域で微生物検査が受け入れられている主要要因は、医薬品製造への注目が高まっていることです。

CAGRが最も高い地域：

予測期間中、アジア太平洋が最も高いCAGRを維持すると予測されています。さまざまな分野で迅速な結果が求められること、法律が厳格化されたこと、微生物学的安全性の重要性に対する理解が深まったことなどが、迅速な微生物検査手順の受け入れ拡大に寄与しています。より迅速で正確な微生物検査技術の開発は、継続的な技術改良によって促進されています。

無料カスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます。

• 企業プロファイル
  • 追加市場参入企業の包括的プロファイリング（3社まで）
  • 主要企業のSWOT分析（3社まで）
• 地域セグメンテーション
  • 顧客の関心に応じた主要国の市場推定・予測・CAGR（注：フィージビリティチェックによる）
• 競合ベンチマーキング
  • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

• 概要
• ステークホルダー
• 調査範囲
• 調査手法
  • データ鉱業
  • データ分析
  • データ検証
  • 調査アプローチ
• 調査ソース
  • 1次調査ソース
  • 2次調査ソース
  • 前提条件

第3章 市場動向分析

• イントロダクション
• 促進要因
• 抑制要因
• 機会
• 脅威
• 製品分析
• 用途分析
• 新興市場
• 新型コロナウイルス感染症（COVID-19）の影響

第4章 ポーターのファイブフォース分析

• 供給企業の交渉力
• 買い手の交渉力
• 代替品の脅威
• 新規参入業者の脅威
• 競争企業間の敵対関係

第5章 世界の迅速微生物検査市場：製品別

• イントロダクション
• 装置
  • アクティブエアサンプラー
  • サイトメーター
  • 質量分析計
  • 生物発光
• 試薬とキット
• 消耗品
• その他の製品

第6章 世界の迅速微生物検査市場：方法別

• イントロダクション
• 生存可能性ベース
• 核酸ベース
• 細胞成分ベース
• 成長ベース
• その他の方法

第7章 世界の迅速微生物検査市場：用途別

• イントロダクション
• 食品と飲料の検査
• 化粧品とパーソナルケア製品の試験
• 医薬品と生物製剤の検査
• 臨床診断検査
• 環境試験
• その他の用途

第8章 世界の迅速微生物検査市場：地域別

• イントロダクション
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン
  • その他の欧州
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • ニュージーランド
  • 韓国
  • その他のアジア太平洋
• 南米
  • アルゼンチン
  • ブラジル
  • チリ
  • その他の南米
• 中東とアフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • カタール
  • 南アフリカ
  • その他の中東とアフリカ

第9章 主要発展

• 契約、パートナーシップ、コラボレーション、合弁事業
• 買収と合併
• 新製品の発売
• 事業拡大
• その他の主要戦略

第10章 企業プロファイル

• Thermo Fisher Scientific Inc.
• Don Whitley Scientific Limited
• Mocon, Inc
• Becton, Dickinson, and Company
• Danaher Corporation
• Merck KGaA
• Rapid Micro Biosystems Inc.
• Vivione Biosciences LLC
• Abbott Laboratories, Inc.
• Quidel Corporation
• Sartorius AG
• iomerieux SA
• NEOGEN Corporation
• Microgenetics

List of Tables

• Table 1 Global Rapid Microbiology Testing Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global Rapid Microbiology Testing Market Outlook, By Product (2021-2030) ($MN)
• Table 3 Global Rapid Microbiology Testing Market Outlook, By Instruments (2021-2030) ($MN)
• Table 4 Global Rapid Microbiology Testing Market Outlook, By Active Air Samplers (2021-2030) ($MN)
• Table 5 Global Rapid Microbiology Testing Market Outlook, By Cytometers (2021-2030) ($MN)
• Table 6 Global Rapid Microbiology Testing Market Outlook, By Mass Spectrometers (2021-2030) ($MN)
• Table 7 Global Rapid Microbiology Testing Market Outlook, By Bioluminescence (2021-2030) ($MN)
• Table 8 Global Rapid Microbiology Testing Market Outlook, By Reagents and kits (2021-2030) ($MN)
• Table 9 Global Rapid Microbiology Testing Market Outlook, By Consumables (2021-2030) ($MN)
• Table 10 Global Rapid Microbiology Testing Market Outlook, By Other Products (2021-2030) ($MN)
• Table 11 Global Rapid Microbiology Testing Market Outlook, By Method (2021-2030) ($MN)
• Table 12 Global Rapid Microbiology Testing Market Outlook, By Viability Based (2021-2030) ($MN)
• Table 13 Global Rapid Microbiology Testing Market Outlook, By Nucleic Acid Based (2021-2030) ($MN)
• Table 14 Global Rapid Microbiology Testing Market Outlook, By Cellular Component Based (2021-2030) ($MN)
• Table 15 Global Rapid Microbiology Testing Market Outlook, By Growth Based (2021-2030) ($MN)
• Table 16 Global Rapid Microbiology Testing Market Outlook, By Other Methods (2021-2030) ($MN)
• Table 17 Global Rapid Microbiology Testing Market Outlook, By Application (2021-2030) ($MN)
• Table 18 Global Rapid Microbiology Testing Market Outlook, By Food and Beverage Testing (2021-2030) ($MN)
• Table 19 Global Rapid Microbiology Testing Market Outlook, By Cosmetics and Personal Care Products Testing (2021-2030) ($MN)
• Table 20 Global Rapid Microbiology Testing Market Outlook, By Pharmaceutical and Biological Drug Testing (2021-2030) ($MN)
• Table 21 Global Rapid Microbiology Testing Market Outlook, By Clinical Disease Diagnosis Testing (2021-2030) ($MN)
• Table 22 Global Rapid Microbiology Testing Market Outlook, By Environmental Testing (2021-2030) ($MN)
• Table 23 Global Rapid Microbiology Testing Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 24 North America Rapid Microbiology Testing Market Outlook, By Country (2021-2030) ($MN)
• Table 25 North America Rapid Microbiology Testing Market Outlook, By Product (2021-2030) ($MN)
• Table 26 North America Rapid Microbiology Testing Market Outlook, By Instruments (2021-2030) ($MN)
• Table 27 North America Rapid Microbiology Testing Market Outlook, By Active Air Samplers (2021-2030) ($MN)
• Table 28 North America Rapid Microbiology Testing Market Outlook, By Cytometers (2021-2030) ($MN)
• Table 29 North America Rapid Microbiology Testing Market Outlook, By Mass Spectrometers (2021-2030) ($MN)
• Table 30 North America Rapid Microbiology Testing Market Outlook, By Bioluminescence (2021-2030) ($MN)
• Table 31 North America Rapid Microbiology Testing Market Outlook, By Reagents and kits (2021-2030) ($MN)
• Table 32 North America Rapid Microbiology Testing Market Outlook, By Consumables (2021-2030) ($MN)
• Table 33 North America Rapid Microbiology Testing Market Outlook, By Other Products (2021-2030) ($MN)
• Table 34 North America Rapid Microbiology Testing Market Outlook, By Method (2021-2030) ($MN)
• Table 35 North America Rapid Microbiology Testing Market Outlook, By Viability Based (2021-2030) ($MN)
• Table 36 North America Rapid Microbiology Testing Market Outlook, By Nucleic Acid Based (2021-2030) ($MN)
• Table 37 North America Rapid Microbiology Testing Market Outlook, By Cellular Component Based (2021-2030) ($MN)
• Table 38 North America Rapid Microbiology Testing Market Outlook, By Growth Based (2021-2030) ($MN)
• Table 39 North America Rapid Microbiology Testing Market Outlook, By Other Methods (2021-2030) ($MN)
• Table 40 North America Rapid Microbiology Testing Market Outlook, By Application (2021-2030) ($MN)
• Table 41 North America Rapid Microbiology Testing Market Outlook, By Food and Beverage Testing (2021-2030) ($MN)
• Table 42 North America Rapid Microbiology Testing Market Outlook, By Cosmetics and Personal Care Products Testing (2021-2030) ($MN)
• Table 43 North America Rapid Microbiology Testing Market Outlook, By Pharmaceutical and Biological Drug Testing (2021-2030) ($MN)
• Table 44 North America Rapid Microbiology Testing Market Outlook, By Clinical Disease Diagnosis Testing (2021-2030) ($MN)
• Table 45 North America Rapid Microbiology Testing Market Outlook, By Environmental Testing (2021-2030) ($MN)
• Table 46 North America Rapid Microbiology Testing Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 47 Europe Rapid Microbiology Testing Market Outlook, By Country (2021-2030) ($MN)
• Table 48 Europe Rapid Microbiology Testing Market Outlook, By Product (2021-2030) ($MN)
• Table 49 Europe Rapid Microbiology Testing Market Outlook, By Instruments (2021-2030) ($MN)
• Table 50 Europe Rapid Microbiology Testing Market Outlook, By Active Air Samplers (2021-2030) ($MN)
• Table 51 Europe Rapid Microbiology Testing Market Outlook, By Cytometers (2021-2030) ($MN)
• Table 52 Europe Rapid Microbiology Testing Market Outlook, By Mass Spectrometers (2021-2030) ($MN)
• Table 53 Europe Rapid Microbiology Testing Market Outlook, By Bioluminescence (2021-2030) ($MN)
• Table 54 Europe Rapid Microbiology Testing Market Outlook, By Reagents and kits (2021-2030) ($MN)
• Table 55 Europe Rapid Microbiology Testing Market Outlook, By Consumables (2021-2030) ($MN)
• Table 56 Europe Rapid Microbiology Testing Market Outlook, By Other Products (2021-2030) ($MN)
• Table 57 Europe Rapid Microbiology Testing Market Outlook, By Method (2021-2030) ($MN)
• Table 58 Europe Rapid Microbiology Testing Market Outlook, By Viability Based (2021-2030) ($MN)
• Table 59 Europe Rapid Microbiology Testing Market Outlook, By Nucleic Acid Based (2021-2030) ($MN)
• Table 60 Europe Rapid Microbiology Testing Market Outlook, By Cellular Component Based (2021-2030) ($MN)
• Table 61 Europe Rapid Microbiology Testing Market Outlook, By Growth Based (2021-2030) ($MN)
• Table 62 Europe Rapid Microbiology Testing Market Outlook, By Other Methods (2021-2030) ($MN)
• Table 63 Europe Rapid Microbiology Testing Market Outlook, By Application (2021-2030) ($MN)
• Table 64 Europe Rapid Microbiology Testing Market Outlook, By Food and Beverage Testing (2021-2030) ($MN)
• Table 65 Europe Rapid Microbiology Testing Market Outlook, By Cosmetics and Personal Care Products Testing (2021-2030) ($MN)
• Table 66 Europe Rapid Microbiology Testing Market Outlook, By Pharmaceutical and Biological Drug Testing (2021-2030) ($MN)
• Table 67 Europe Rapid Microbiology Testing Market Outlook, By Clinical Disease Diagnosis Testing (2021-2030) ($MN)
• Table 68 Europe Rapid Microbiology Testing Market Outlook, By Environmental Testing (2021-2030) ($MN)
• Table 69 Europe Rapid Microbiology Testing Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 70 Asia Pacific Rapid Microbiology Testing Market Outlook, By Country (2021-2030) ($MN)
• Table 71 Asia Pacific Rapid Microbiology Testing Market Outlook, By Product (2021-2030) ($MN)
• Table 72 Asia Pacific Rapid Microbiology Testing Market Outlook, By Instruments (2021-2030) ($MN)
• Table 73 Asia Pacific Rapid Microbiology Testing Market Outlook, By Active Air Samplers (2021-2030) ($MN)
• Table 74 Asia Pacific Rapid Microbiology Testing Market Outlook, By Cytometers (2021-2030) ($MN)
• Table 75 Asia Pacific Rapid Microbiology Testing Market Outlook, By Mass Spectrometers (2021-2030) ($MN)
• Table 76 Asia Pacific Rapid Microbiology Testing Market Outlook, By Bioluminescence (2021-2030) ($MN)
• Table 77 Asia Pacific Rapid Microbiology Testing Market Outlook, By Reagents and kits (2021-2030) ($MN)
• Table 78 Asia Pacific Rapid Microbiology Testing Market Outlook, By Consumables (2021-2030) ($MN)
• Table 79 Asia Pacific Rapid Microbiology Testing Market Outlook, By Other Products (2021-2030) ($MN)
• Table 80 Asia Pacific Rapid Microbiology Testing Market Outlook, By Method (2021-2030) ($MN)
• Table 81 Asia Pacific Rapid Microbiology Testing Market Outlook, By Viability Based (2021-2030) ($MN)
• Table 82 Asia Pacific Rapid Microbiology Testing Market Outlook, By Nucleic Acid Based (2021-2030) ($MN)
• Table 83 Asia Pacific Rapid Microbiology Testing Market Outlook, By Cellular Component Based (2021-2030) ($MN)
• Table 84 Asia Pacific Rapid Microbiology Testing Market Outlook, By Growth Based (2021-2030) ($MN)
• Table 85 Asia Pacific Rapid Microbiology Testing Market Outlook, By Other Methods (2021-2030) ($MN)
• Table 86 Asia Pacific Rapid Microbiology Testing Market Outlook, By Application (2021-2030) ($MN)
• Table 87 Asia Pacific Rapid Microbiology Testing Market Outlook, By Food and Beverage Testing (2021-2030) ($MN)
• Table 88 Asia Pacific Rapid Microbiology Testing Market Outlook, By Cosmetics and Personal Care Products Testing (2021-2030) ($MN)
• Table 89 Asia Pacific Rapid Microbiology Testing Market Outlook, By Pharmaceutical and Biological Drug Testing (2021-2030) ($MN)
• Table 90 Asia Pacific Rapid Microbiology Testing Market Outlook, By Clinical Disease Diagnosis Testing (2021-2030) ($MN)
• Table 91 Asia Pacific Rapid Microbiology Testing Market Outlook, By Environmental Testing (2021-2030) ($MN)
• Table 92 Asia Pacific Rapid Microbiology Testing Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 93 South America Rapid Microbiology Testing Market Outlook, By Country (2021-2030) ($MN)
• Table 94 South America Rapid Microbiology Testing Market Outlook, By Product (2021-2030) ($MN)
• Table 95 South America Rapid Microbiology Testing Market Outlook, By Instruments (2021-2030) ($MN)
• Table 96 South America Rapid Microbiology Testing Market Outlook, By Active Air Samplers (2021-2030) ($MN)
• Table 97 South America Rapid Microbiology Testing Market Outlook, By Cytometers (2021-2030) ($MN)
• Table 98 South America Rapid Microbiology Testing Market Outlook, By Mass Spectrometers (2021-2030) ($MN)
• Table 99 South America Rapid Microbiology Testing Market Outlook, By Bioluminescence (2021-2030) ($MN)
• Table 100 South America Rapid Microbiology Testing Market Outlook, By Reagents and kits (2021-2030) ($MN)
• Table 101 South America Rapid Microbiology Testing Market Outlook, By Consumables (2021-2030) ($MN)
• Table 102 South America Rapid Microbiology Testing Market Outlook, By Other Products (2021-2030) ($MN)
• Table 103 South America Rapid Microbiology Testing Market Outlook, By Method (2021-2030) ($MN)
• Table 104 South America Rapid Microbiology Testing Market Outlook, By Viability Based (2021-2030) ($MN)
• Table 105 South America Rapid Microbiology Testing Market Outlook, By Nucleic Acid Based (2021-2030) ($MN)
• Table 106 South America Rapid Microbiology Testing Market Outlook, By Cellular Component Based (2021-2030) ($MN)
• Table 107 South America Rapid Microbiology Testing Market Outlook, By Growth Based (2021-2030) ($MN)
• Table 108 South America Rapid Microbiology Testing Market Outlook, By Other Methods (2021-2030) ($MN)
• Table 109 South America Rapid Microbiology Testing Market Outlook, By Application (2021-2030) ($MN)
• Table 110 South America Rapid Microbiology Testing Market Outlook, By Food and Beverage Testing (2021-2030) ($MN)
• Table 111 South America Rapid Microbiology Testing Market Outlook, By Cosmetics and Personal Care Products Testing (2021-2030) ($MN)
• Table 112 South America Rapid Microbiology Testing Market Outlook, By Pharmaceutical and Biological Drug Testing (2021-2030) ($MN)
• Table 113 South America Rapid Microbiology Testing Market Outlook, By Clinical Disease Diagnosis Testing (2021-2030) ($MN)
• Table 114 South America Rapid Microbiology Testing Market Outlook, By Environmental Testing (2021-2030) ($MN)
• Table 115 South America Rapid Microbiology Testing Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 116 Middle East & Africa Rapid Microbiology Testing Market Outlook, By Country (2021-2030) ($MN)
• Table 117 Middle East & Africa Rapid Microbiology Testing Market Outlook, By Product (2021-2030) ($MN)
• Table 118 Middle East & Africa Rapid Microbiology Testing Market Outlook, By Instruments (2021-2030) ($MN)
• Table 119 Middle East & Africa Rapid Microbiology Testing Market Outlook, By Active Air Samplers (2021-2030) ($MN)
• Table 120 Middle East & Africa Rapid Microbiology Testing Market Outlook, By Cytometers (2021-2030) ($MN)
• Table 121 Middle East & Africa Rapid Microbiology Testing Market Outlook, By Mass Spectrometers (2021-2030) ($MN)
• Table 122 Middle East & Africa Rapid Microbiology Testing Market Outlook, By Bioluminescence (2021-2030) ($MN)
• Table 123 Middle East & Africa Rapid Microbiology Testing Market Outlook, By Reagents and kits (2021-2030) ($MN)
• Table 124 Middle East & Africa Rapid Microbiology Testing Market Outlook, By Consumables (2021-2030) ($MN)
• Table 125 Middle East & Africa Rapid Microbiology Testing Market Outlook, By Other Products (2021-2030) ($MN)
• Table 126 Middle East & Africa Rapid Microbiology Testing Market Outlook, By Method (2021-2030) ($MN)
• Table 127 Middle East & Africa Rapid Microbiology Testing Market Outlook, By Viability Based (2021-2030) ($MN)
• Table 128 Middle East & Africa Rapid Microbiology Testing Market Outlook, By Nucleic Acid Based (2021-2030) ($MN)
• Table 129 Middle East & Africa Rapid Microbiology Testing Market Outlook, By Cellular Component Based (2021-2030) ($MN)
• Table 130 Middle East & Africa Rapid Microbiology Testing Market Outlook, By Growth Based (2021-2030) ($MN)
• Table 131 Middle East & Africa Rapid Microbiology Testing Market Outlook, By Other Methods (2021-2030) ($MN)
• Table 132 Middle East & Africa Rapid Microbiology Testing Market Outlook, By Application (2021-2030) ($MN)
• Table 133 Middle East & Africa Rapid Microbiology Testing Market Outlook, By Food and Beverage Testing (2021-2030) ($MN)
• Table 134 Middle East & Africa Rapid Microbiology Testing Market Outlook, By Cosmetics and Personal Care Products Testing (2021-2030) ($MN)
• Table 135 Middle East & Africa Rapid Microbiology Testing Market Outlook, By Pharmaceutical and Biological Drug Testing (2021-2030) ($MN)
• Table 136 Middle East & Africa Rapid Microbiology Testing Market Outlook, By Clinical Disease Diagnosis Testing (2021-2030) ($MN)
• Table 137 Middle East & Africa Rapid Microbiology Testing Market Outlook, By Environmental Testing (2021-2030) ($MN)
• Table 138 Middle East & Africa Rapid Microbiology Testing Market Outlook, By Other Applications (2021-2030) ($MN)

According to Stratistics MRC, the Global Rapid Microbiology Testing Market is accounted for $4.7 billion in 2023 and is expected to reach $9.7 billion by 2030 growing at a CAGR of 10.8% during the forecast period. Microbiology testing is done quickly to identify potential health threats from microorganisms early on, monitor vital control points in real time, optimize production processes, boost product safety, and lower overall quality procedure costs. Rapid microbiological testing is a technology used in drug development, research, and other diagnostic applications. Rapid microbiological testing is used to help diagnose infections like TB and malaria quickly. This aids in the treatment of lower respiratory tract infections. When compared to conventional testing based on culture, these tests yield speedier findings.

According to the PHAC, there were over 225,000 reported cases of notifiable infectious diseases in Canada in 2021, including sexually transmitted infections, foodborne illnesses, and respiratory infections.

Market Dynamics:

Driver:

Rising rates of infectious illnesses

Infectious illnesses including malaria, HIV, pneumonia, and TB are becoming more common. Programs to raise awareness of infectious diseases including HIV, cancer, TB, and pneumonia have become more prevalent in an effort to promote early detection and preventative healthcare, which can lead to better treatment outcomes. The increased global burden of these disorders will probably result in a significant rise in demand for fast microbiological procedures throughout the forecast period.

Restraint:

Inadequate healthcare services

Many individuals in underdeveloped nations lack access to healthcare facilities and the necessary information to maintain their health. Additionally, a major barrier to public health is a lack of funding, which exacerbates the problem of infectious illnesses, which is a serious public health concern. Furthermore, the majority of poor nations' healthcare systems struggle to staff with qualified professionals, which makes it challenging for them to offer access to high-quality medical services like quick microbiological testing. This reflects the impediment to the market's expansion.

Opportunity:

Increasing concerns about food safety

Food items consist of both plants and animals, and they typically include a range of microbes. During the production and consumption stages, food may come into touch with natural source microbes and get contaminated. To guarantee that the food and beverage sectors provide customers with the highest level of product safety and quality, regulatory bodies regularly update food safety laws. As a result, growth in the market is anticipated throughout the forecast period.

Threat:

High equipment cost

Rapid procedures may incur greater initial setup expenses for equipment compared to older approaches. For smaller labs or institutions with tighter funds, this might be a hindrance. Test kits and cartridges, among other consumables used in quick techniques, can be costly. These expenses have the potential to accumulate over time and eventually outweigh those related to conventional techniques. These are the things impeding the market's expansion.

COVID-19 Impact:

At the early phase of pandemic, there was no availability of specific diagnostic tests to detect the disease in patients. Alternative diagnostic tests were used initially but were not much effective. This unavailability of specific COVID-19 diagnostic tests presented lucrative opportunities for diagnostic manufacturers to introduce their diagnostic kits. Many leading players as well as some start-ups from various countries utilized this opportunity and introduced diagnostics kits into local as well as global market. These players achieved edge over other diagnostics players capitalizing the opportunity from demand for diagnostic tests, which, in turn, helps them in maintaining their revenues in such a crisis.

The cellular component based segment is expected to be the largest during the forecast period

The cellular component based segment is expected to be the largest during the forecast period, owing to more accurate and more sensitive detection of microbial pathogens, which is crucial for effective treatment and control of infectious diseases. Rapid microbiological testing based on cellular components is used to diagnose a number of serious conditions, such as foodborne infections, infections linked to healthcare, and infectious diseases. The market is anticipated to keep expanding in the future due to the growing need for quicker and more precise diagnostic tests for these illnesses.

The clinical diagnosis testing segment is expected to have the highest CAGR during the forecast period

The clinical diagnosis testing segment is expected to have the highest CAGR during the forecast period. In order to identify and categorize infectious bacteria in clinical samples including blood, urine, and sputum, rapid microbiology testing methods are employed in clinical diagnosis. Rapid microbiological testing methods are becoming more and more necessary in clinical settings as infectious illnesses become more common. Technological advancements in testing methodologies have improved testing accuracy and efficiency, hence encouraging their usage in clinical diagnostics across the industry.

Region with largest share:

North America is projected to hold the largest market share during the forecast period. The market is expanding due to a number of factors, including the increased emphasis on the creation of drugs and vaccines, recent developments in biotechnology and pharmaceutical research, and the availability of several vendors in the nation that provide a broad selection of microbial testing products. Thus, a key factor in the region's acceptance of microbiological testing has been the increased focus on medication manufacture.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period. The demand for quicker results in a variety of sectors, stricter laws, and a growing understanding of the significance of microbiological safety have all contributed to the growing acceptance of rapid microbiology testing procedures. The development of more quick and precise microbiological testing techniques is facilitated by ongoing technological improvements.

Key players in the market:

Some of the key players in Rapid Microbiology Testing market include Thermo Fisher Scientific Inc., Don Whitley Scientific Limited, Mocon, Inc, Becton, Dickinson, and Company, Danaher Corporation, Merck KGaA, Rapid Micro Biosystems Inc., Vivione Biosciences LLC, Abbott Laboratories, Inc., Quidel Corporation, Sartorius AG, Biomerieux SA, NEOGEN Corporation and Microgenetics.

Key Developments:

In September 2022, Microgenetics developed a Rapid Microbial Method with a six-hour turnaround time. This crucial stage is costing many businesses time and resources because compendial methods of microbial contamination tests have a turnaround time of 14 days, and even faster technologies take about 4 days.

In August 2022, Together, BD and Accelerate Diagnostics are fighting antibiotic resistance. Through a global commercial partnership, BD will make available Accelerate's rapid testing solution for antibiotic resistance and susceptibility, which provides results in hours as opposed to one to two days, as is the case with some conventional laboratory techniques.

Products Covered:

• Instruments
• Reagents and kits
• Consumables
• Other Products

Methods Covered:

• Viability Based
• Nucleic Acid Based
• Cellular Component Based
• Growth Based
• Other Methods

Applications Covered:

• Food and Beverage Testing
• Cosmetics and Personal Care Products Testing
• Pharmaceutical and Biological Drug Testing
• Clinical Disease Diagnosis Testing
• Environmental Testing
• Other Applications

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Application Analysis
• 3.9 Emerging Markets
• 3.10 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Rapid Microbiology Testing Market, By Product

• 5.1 Introduction
• 5.2 Instruments
  • 5.2.1 Active Air Samplers
  • 5.2.2 Cytometers
  • 5.2.3 Mass Spectrometers
  • 5.2.4 Bioluminescence
• 5.3 Reagents and kits
• 5.4 Consumables
• 5.5 Other Products

6 Global Rapid Microbiology Testing Market, By Method

• 6.1 Introduction
• 6.2 Viability Based
• 6.3 Nucleic Acid Based
• 6.4 Cellular Component Based
• 6.5 Growth Based
• 6.6 Other Methods

7 Global Rapid Microbiology Testing Market, By Application

• 7.1 Introduction
• 7.2 Food and Beverage Testing
• 7.3 Cosmetics and Personal Care Products Testing
• 7.4 Pharmaceutical and Biological Drug Testing
• 7.5 Clinical Disease Diagnosis Testing
• 7.6 Environmental Testing
• 7.7 Other Applications

8 Global Rapid Microbiology Testing Market, By Geography

• 8.1 Introduction
• 8.2 North America
  • 8.2.1 US
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 Italy
  • 8.3.4 France
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 New Zealand
  • 8.4.6 South Korea
  • 8.4.7 Rest of Asia Pacific
• 8.5 South America
  • 8.5.1 Argentina
  • 8.5.2 Brazil
  • 8.5.3 Chile
  • 8.5.4 Rest of South America
• 8.6 Middle East & Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 UAE
  • 8.6.3 Qatar
  • 8.6.4 South Africa
  • 8.6.5 Rest of Middle East & Africa

9 Key Developments

• 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 9.2 Acquisitions & Mergers
• 9.3 New Product Launch
• 9.4 Expansions
• 9.5 Other Key Strategies

10 Company Profiling

• 10.1 Thermo Fisher Scientific Inc.
• 10.2 Don Whitley Scientific Limited
• 10.3 Mocon, Inc
• 10.4 Becton, Dickinson, and Company
• 10.5 Danaher Corporation
• 10.6 Merck KGaA
• 10.7 Rapid Micro Biosystems Inc.
• 10.8 Vivione Biosciences LLC
• 10.9 Abbott Laboratories, Inc.
• 10.10 Quidel Corporation
• 10.11 Sartorius AG
• 10.12 iomerieux SA
• 10.13 NEOGEN Corporation
• 10.14 Microgenetics